Centre de Référence pour les Maladies Osseuses Constitutionnelles, Fédération de médecine génomique des maladies rares, APHP, Hôpital Necker-Enfants Malades, F-75015 Paris, France.
Université Paris Cité, INSERM UMR1163, Institut Imagine, F-75 015, Paris, France.
J Med Genet. 2024 Jan 19;61(2):109-116. doi: 10.1136/jmg-2023-109288.
Weill-Marchesani syndrome (WMS) belongs to the group of acromelic dysplasias, defined by short stature, brachydactyly and joint limitations. WMS is characterised by specific ophthalmological abnormalities, although cardiovascular defects have also been reported. Monoallelic variations in are associated with a dominant form of WMS, while biallelic variations in , and are responsible for a recessive form of WMS.
Natural history description of WMS and genotype-phenotype correlation establishment.
Retrospective multicentre study and literature review.
clinical diagnosis of WMS with identified pathogenic variants.
61 patients were included: 18 individuals from our cohort and 43 patients from literature. 21 had variants in , 19 in , 19 in and 2 in . All individuals presented with eye anomalies, mainly spherophakia (42/61) and ectopia lentis (39/61). Short stature was present in 73% (from -2.2 to -5.5 SD), 10/61 individuals had valvulopathy. Regarding variants, patients with a variant located in transforming growth factor (TGF)-β-binding protein-like domain 5 (TB5) domain were significantly smaller than patients with variant outside TB5 domain (p=0.0040).
Apart from the ophthalmological findings, which are mandatory for the diagnosis, the phenotype of WMS seems to be more variable than initially described, partially explained by genotype-phenotype correlation.
Weill-Marchesani 综合征(WMS)属于肢端短小症畸形,其特征为身材矮小、短指(趾)和关节僵硬。WMS 还伴有特定的眼科异常,尽管也有心血管缺陷的报道。编码 TGF-β结合蛋白样域 5(TB5)的 单等位基因变异与显性形式的 WMS 相关,而编码 、 和 的双等位基因变异与隐性形式的 WMS 相关。
描述 WMS 的自然病史并建立基因型-表型相关性。
回顾性多中心研究和文献复习。
临床诊断为 WMS 并鉴定出致病性变异。
共纳入 61 例患者:18 例来自我们的队列,43 例来自文献。21 例患者存在 变异,19 例存在 变异,19 例存在 变异,2 例存在 变异。所有患者均存在眼部异常,主要为球形晶状体(42/61)和晶状体异位(39/61)。73%(-2.2 至-5.5 个标准差)的患者身材矮小,10/61 例患者存在瓣膜病。关于 变异,位于转化生长因子(TGF)-β结合蛋白样域 5(TB5)域内的患者明显比 TB5 域外的患者矮小(p=0.0040)。
除了必须的眼科发现外,WMS 的表型似乎比最初描述的更为多样,部分原因是基因型-表型相关性。